Precigen (PGEN) Cash from Financing Activities (2012 - 2026)

Precigen's (PGEN) quarterly Cash from Financing Activities came in at $109000.0 in Q1 2026, up 116.05% year-on-year from $50450.6 in Q1 2025, and up 121.21% on a QoQ basis from -$514000.0 in Q4 2025.

Precigen (PGEN) Cash from Financing Activities (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Cash from Financing Activities data on file, last reported at $109000.0 in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 116.05% year-over-year to $109000.0 in Q1 2026; TTM through Mar 2026 was $90.8 million, a 17.35% decrease from a year earlier, with the FY2025 full-year figure at $90.0 million, down 18.57% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $109000.0, up from -$514000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for PGEN reached as high as $93.0 million in Q3 2025 and fell as low as -$115.7 million in Q3 2022.
  • Historically, Cash from Financing Activities has averaged $5.4 million across 5 years, with a median of -$138000.0 in 2022.
  • Across the five-year window, Cash from Financing Activities plunged 49558.97% in 2022 and surged 27200.61% in 2023, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$39.3 million in 2022, then surged by 62.87% to -$14.6 million in 2023, then surged by 637.57% to $78.4 million in 2024, then sank by 100.66% to -$514000.0 in 2025, then jumped by 121.21% to $109000.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $109000.0 in Q1 2026, -$514000.0 in Q4 2025, and $93.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn 109,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 109,000.00
Mar 31, 2026 109,000.00
Dec 31, 2025 -514,000.00
Dec 31, 2025 -514,000.00
Sep 30, 2025 93.01 Mn
Sep 30, 2025 93.01 Mn
Jun 30, 2025 -1.77 Mn
Jun 30, 2025 -1.77 Mn
Mar 31, 2025 -679,000.00
Mar 31, 2025 -679,000.00
Dec 31, 2024 78.40 Mn
Dec 31, 2024 78.40 Mn
Sep 30, 2024 32.13 Mn
Sep 30, 2024 32.13 Mn
Jun 30, 2024 52,000.00
Jun 30, 2024 52,000.00
Jun 30, 2023 -14.59 Mn
Jun 30, 2023 -14.59 Mn
Mar 31, 2023 44.17 Mn
Mar 31, 2023 44.17 Mn